Chae-Yong Kim Selected Research

Chae-Yong Kim Research Topics

Disease

31	Neoplasms (Cancer) 04/2022 - 12/2002
30	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2009
22	Glioma (Gliomas) 04/2022 - 09/2003
7	Brain Neoplasms (Brain Tumor) 04/2022 - 01/2012
4	Neoplasm Metastasis (Metastasis) 04/2021 - 03/2013
4	Neurocytoma 04/2016 - 02/2003
3	Atrophy 06/2020 - 12/2010
3	Meningioma (Meningiomas) 01/2019 - 12/2002
3	Astrocytoma (Pilocytic Astrocytoma) 07/2018 - 01/2011
3	Medulloblastoma 01/2018 - 03/2011
2	Seizures (Absence Seizure) 04/2022 - 09/2013
2	Edema (Dropsy) 06/2020 - 12/2002
2	Ependymoma 01/2020 - 01/2011
2	Drug Resistant Epilepsy 06/2015 - 07/2013
2	Thrombocytopenia (Thrombopenia) 09/2014 - 09/2013
2	Brain Edema (Cerebral Edema) 12/2010 - 10/2007
1	Dyspnea (Shortness of Breath) 04/2022
1	Fatigue 04/2022
1	Vomiting 04/2022
1	Alopecia (Baldness) 04/2022
1	Constipation 04/2022
1	Diarrhea 04/2022
1	Nausea 04/2022
1	Residual Neoplasm 01/2021
1	Cognitive Dysfunction 06/2020
1	Acute Kidney Injury (Acute Renal Failure) 07/2019
1	Germinoma 11/2018
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018
1	Hearing Loss (Hearing Impairment) 10/2017
1	Low Back Pain (Lumbago) 01/2017
1	Spondylolisthesis 01/2017
1	Pituitary Apoplexy 10/2016
1	Central Nervous System Cysts (Suprasellar Cyst) 10/2016
1	Ganglion Cysts (Ganglion) 11/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2015
1	Disease Progression 09/2014
1	Lymphopenia (Lymphocytopenia) 09/2014
1	Neutropenia 09/2014
1	Pancytopenia 09/2013
1	Supratentorial Neoplasms 09/2013
1	Cerebrospinal Fluid Leak 08/2013
1	Moyamoya Disease (Moya-Moya Disease) 04/2013
1	Cerebral Infarction 04/2013

Drug/Important Bio-Agent (IBA)

25	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 10/2008
3	Antimitotic AgentsIBA 01/2022 - 12/2017
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 09/2013
3	MethyltransferasesIBA 07/2021 - 08/2009
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2013
3	CamptothecinIBA 08/2013 - 06/2009
3	belotecanIBA 08/2013 - 06/2009
3	Cisplatin (Platino)FDA LinkGeneric 07/2011 - 01/2009
3	NimustineIBA 07/2011 - 01/2009
2	O-(6)-methylguanineIBA 07/2021 - 02/2011
2	Tromethamine (Trometamol)FDA Link 01/2018 - 05/2017
2	SaltsIBA 01/2018 - 05/2017
2	7-O-succinyl macrolactin AIBA 01/2018 - 05/2017
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2015 - 09/2013
2	CilengitideIBA 09/2014 - 08/2013
2	Indicators and Reagents (Reagents)IBA 11/2012 - 12/2010
2	Biological ProductsIBA 01/2012 - 12/2002
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2021
1	olaparibIBA 07/2021
1	ORALIT (ORS)IBA 06/2020
1	Pemetrexed (MTA)FDA Link 06/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2018
1	Growth Factor ReceptorsIBA 11/2018
1	Phenobarbital (Luminal)FDA Link 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	Procarbazine (Matulane)FDA Link 06/2018
1	Vincristine (Oncovin)FDA LinkGeneric 06/2018
1	Lomustine (CCNU)FDA Link 06/2018
1	LigandsIBA 02/2018
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Retinaldehyde (Retinal)IBA 11/2015
1	Methotrexate (Mexate)FDA LinkGeneric 10/2015
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 10/2015
1	IntegrinsIBA 09/2014
1	GadoliniumIBA 01/2014
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2013
1	Therapeutic UsesIBA 08/2013
1	TransferasesIBA 02/2012

Therapy/Procedure

25	Radiotherapy 04/2022 - 02/2003
15	Chemoradiotherapy 04/2022 - 10/2008
15	Therapeutics 07/2021 - 11/2007
10	Drug Therapy (Chemotherapy) 04/2021 - 01/2009
8	Adjuvant Chemotherapy 01/2022 - 10/2008
5	Aftercare (After-Treatment) 11/2018 - 04/2012
4	Craniotomy 07/2019 - 02/2003
3	Salvage Therapy 04/2022 - 01/2012
3	Adjuvant Radiotherapy 04/2021 - 04/2016
3	Conservative Treatment 01/2020 - 10/2016
3	Anesthesia 01/2017 - 07/2013
2	Lasers (Laser) 01/2009 - 12/2002
1	Immunotherapy 09/2018
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2018
1	Laminectomy 01/2017
1	Suction (Suction Drainage) 08/2013
1	Microvascular Decompression Surgery 08/2013